Key Takeaways
Helping patients stay on treatment requires more than reminders and routine follow-up. The reasons patients disengage are often personal, interconnected, and subject to change over time. A more effective approach begins by understanding the specific barriers affecting each patient and adapting support as their needs and circumstances evolve.
- Non-adherence can lead to disease progression, hospitalization, and irreversible complications, while adding strain to healthcare systems already stretched thin.
- Standardized approaches to treatment adherence can result in lost investment for interventions that only work for some patients.
- Understanding why a patient may struggle to stay on treatment should come before intervention.
- Every patient is different and adherence solutions should be tailored to their needs, with support adapting over time as patient needs change.
Why One-Size-Fits-All Adherence Programs Fall Short
Patients do not stop taking treatment for a single reason.
For one person, the challenge may be side effects or concerns about treatment. For another, it may be the cost of care, a demanding work schedule, difficulty getting to appointments, or the challenge of managing multiple medications. For someone else, the barrier may be a lack of understanding about their condition or limited support from family and caregivers.
These challenges can also change over time.
What helps a patient remain on treatment during the first month may not address the barriers they face six months later. A patient who begins treatment with strong motivation and support may encounter new challenges as side effects emerge, routines change, or the demands of long-term treatment begin to affect daily life.
Yet adherence support has often relied on a relatively limited set of interventions. Patients may receive education about the importance of treatment, reminders to take medication, and standardized follow-up at predetermined intervals. These approaches can be valuable, but they do not always account for why a particular patient is struggling or whether their needs have changed.
The consequences of getting this wrong can be significant. Non-adherence to prescribed treatment can contribute to disease progression, hospitalization, reduced quality of life, and serious or irreversible complications. It can also increase pressure on healthcare providers and health systems that are already managing growing demand and limited resources.
The challenge is particularly significant for patients managing chronic conditions, where treatment may continue for years or even a lifetime. Remaining on therapy requires patients to continually integrate treatment into their everyday lives while navigating changes in their health, circumstances, and priorities.
This is why adherence cannot be understood through a diagnosis alone.
The World Health Organization has long recognized that adherence is influenced by multiple factors. Its five dimensions of adherence include social and economic factors, healthcare system-related factors, therapy-related factors, condition-related factors, and patient-related factors. Together, these dimensions highlight an important reality: whether a patient stays on treatment is shaped by much more than their willingness to follow medical advice.
A patient may understand exactly why treatment is important and still struggle to remain adherent.
The question, then, is not simply how to remind patients to stay on treatment. It is how to understand what is getting in the way.
How Personalized Adherence Assessments Can Change the Outcome
Care and treatment are only part of the picture.
What determines whether someone stays on treatment often lies in the rest of their life: their routines, responsibilities, financial circumstances, support systems, beliefs about treatment, and the practical challenges they encounter along the way.
That is why personalized adherence support should begin with assessment.
A meaningful assessment helps identify the specific factors that may affect a patient’s ability or willingness to remain on treatment. It creates a more complete picture of the patient and provides a foundation for determining what type of support may be most appropriate.
At Axios, this approach is informed by the Patient Needs Assessment Tool, or PNAT, an evidence-based tool designed to identify factors that may place patients at risk of disengaging from treatment. The assessment considers the multiple dimensions that can influence adherence and helps guide the development of more personalized patient support.
The distinction matters because two patients with the same diagnosis may need entirely different interventions.
One patient may be struggling with side effects and avoiding follow-up appointments because they are concerned about discussing missed doses with their healthcare provider. Another may be managing the same condition but frequently skip treatment because of a demanding schedule, frequent travel, and limited understanding of the consequences of non-adherence.
Sending both patients the same reminder or enrolling them in the same standardized support program is unlikely to address either patient’s actual barrier. The goal of assessment is to better understand what support could make a meaningful difference for that individual patient.
That support might involve additional education, help navigating treatment, remote care, financial support, more flexible services, or another intervention designed around the patient’s specific circumstances.
Just as importantly, that support may need to change over time.
What It Takes to Make Personalized Support Work at Scale
Personalization does not mean creating an entirely different program for every patient. It means building enough flexibility into a support model to recognize meaningful differences between patients and respond to them in a structured way.
That requires a combination of scientific assessment, patient engagement, appropriate interventions, and ongoing evaluation. It also requires collaboration among the different stakeholders involved in the patient journey, including healthcare providers, patient support teams, researchers, and others working to understand what affects treatment outcomes.
Technology and data can also play an important role, particularly when they help identify patterns, monitor changing needs, and support more timely interventions. But technology alone cannot explain why an individual patient is struggling.
That still requires an understanding of the person behind the data.
At Axios, our experience supporting patients across different diseases and healthcare settings has reinforced the importance of looking beyond a single barrier to adherence. Patients rarely experience challenges in isolation. Financial pressures can affect motivation. Side effects can influence a patient’s perception of treatment. A demanding lifestyle can make an already complicated regimen harder to maintain.
The most effective approach is therefore rarely a single intervention.
It is a structured and holistic approach that helps identify the factors affecting each patient, connects those factors to appropriate support, and continues to adapt as the patient’s journey evolves.
